VIASKIN

Learn about DBV Technologies, a global clinical stage biopharmaceutical company dedicated to the development of safe and effective food allergy treatments... Today, we are focused on exploring the use of Viaskin to address food allergies, a devastating condition that afflicts millions of patients. As an important milestone in our journey, we hope to offer the first epicutaneous immunotherapy treatment for peanut allergy.

VAT numbers: FR79441772522

Primary location: Basking Ridge United States